Omniab, inc.OABI.US Overview
OABI Overall Performance
OABI AI Analysis & Strategy
OABI Recent Performance
5.15%
Omniab, inc.
1.30%
Avg of Sector
0.61%
S&P500
OABI PowerScanner
OABI Key Information
OABI Valuation Metrics
OABI Earnings Table
OABI Profile
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.